0.013862
0.008003
0.000000
0.000000
0.016006
0.000000
0.000000
0.000000
0.010597
0.00000
0.00000
0.00000
Ahn, V.E.
Faull, K.F.
Whitelegge, J.P.
Fluharty, A.L.
Prive, G.G.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
18
90.00
90.00
120.00
72.140
72.140
94.366
C41 H82 N O8 P
748.065
1,2-Distearoyl-sn-glycerophosphoethanolamine
3-SN-PHOSPHATIDYLETHANOLAMINE; 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE
non-polymer
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Proc.Natl.Acad.Sci.USA
PNASA6
0040
0027-8424
100
38
43
10.1073/pnas.0136947100
12518053
Crystal Structure of saposin B reveals a dimeric shell for lipid binding
2003
US
Protein Expr.Purif.
PEXPEJ
0757
1046-5928
27
186
193
10.1016/S1046-5928(02)00597-1
Expression, purification, crystallization and preliminary X-ray analysis of recombinant human saposin B
2003
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100
1
CCD
2000-04-21
ADSC QUANTUM 4
MAD, SE-MET
M
x-ray
1
0.9789
1.0
0.9793
1.0
F2
CHESS
0.9789, 0.9793
SYNCHROTRON
CHESS BEAMLINE F2
9128.529
SAPOSIN B
3
man
polymer
748.065
1,2-Distearoyl-sn-glycerophosphoethanolamine
1
syn
non-polymer
18.015
water
90
nat
water
Proactivator polypeptide, Sap-B, Sphingolipid activator protein 1, SAP-1, Cerebroside sulfate activator, CSAct, CS-Act, Sulfatide/GM1 activator, GALACTOSYLCERBROSIDE ACTIVATOR
no
no
MDGDVCQDCIQMVTDIQTAVRTNSTFVQALVEHVKEECDRLGPGMADICKNYISQYSEIAIQMMMHMQPKEICALVGFCD
E
MDGDVCQDCIQMVTDIQTAVRTNSTFVQALVEHVKEECDRLGPGMADICKNYISQYSEIAIQMMMHMQPKEICALVGFCD
E
A,B,C
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
Prosaposin, PSAP
9606
Homo sapiens
562
Escherichia coli
AD494(DE3)
plasmid
PET-16(B)
1
2.68
54
VAPOR DIFFUSION, HANGING DROP
5.8
POLYETHYLENE GLYCOL 3350, MAGNESIUM ACETATE,
SODIUM CACODYLATE, PH 5.8, VAPOR DIFFUSION, HANGING DROP,
TEMPERATURE 295K. THE CRYSTAL WAS TREATED WITH A MOTHER
LIQUOR SOLUTION CONTAINING 0.1% HYDROGEN PEROXIDE PRIOR
TO FREEZING.
295
software
atom_site
chem_comp
entity
pdbx_distant_solvent_atoms
pdbx_entity_nonpoly
pdbx_nonpoly_scheme
pdbx_unobs_or_zero_occ_atoms
struct_ref_seq_dif
struct_site
repository
Initial release
Version format compliance
Version format compliance
Refinement description
Advisory
Atomic model
Data collection
Database references
Derived calculations
Non-polymer description
Structure summary
1
0
2003-01-07
1
1
2008-04-28
1
2
2011-07-13
1
3
2017-10-11
2
0
2021-06-30
_atom_site.B_iso_or_equiv
_atom_site.Cartn_x
_atom_site.Cartn_y
_atom_site.Cartn_z
_atom_site.auth_comp_id
_atom_site.label_comp_id
_chem_comp.formula
_chem_comp.formula_weight
_chem_comp.id
_chem_comp.mon_nstd_flag
_chem_comp.name
_chem_comp.pdbx_synonyms
_chem_comp.type
_entity.pdbx_description
_pdbx_entity_nonpoly.comp_id
_pdbx_entity_nonpoly.name
_pdbx_nonpoly_scheme.mon_id
_pdbx_nonpoly_scheme.pdb_mon_id
_pdbx_unobs_or_zero_occ_atoms.auth_comp_id
_pdbx_unobs_or_zero_occ_atoms.label_comp_id
_struct_ref_seq_dif.details
_struct_site.details
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
BIOLOGICAL_UNIT: HOMODIMER
OTHER DETAILS: METHIONINES SUBSTITUTED WITH SELENOMETHIONINE
HETEROGEN
The PEH ligand is disordered and is probably a
mixture of phosphatidylethanolamines with different
acyl chain lengths. This ensemble has been modelled
as a single phospholipid. As a result, the PEH atoms
C2I, C3F, C3G, C3H and C3I are not present in this model.
WARNING
1N69: THE PEH LIGAND IS DISORDERED
BIOMOLECULE: 1, 2
THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT
WHICH CONSISTS OF 3 CHAINS (A,B AND C). CHAINS A AND B FORM
AN ASYMMETRIC HOMODIMER. CHAIN C FORMS A HOMODIMER
WITH A CRYSTALLOGRAPHICALLY RELATED SYMMETRY MATE.
SEE REMARK 350 FOR INFORMATION ON GENERATING THE BIOLOGICAL
MOLECULE(S).
RCSB
Y
RCSB
2002-11-08
REL
REL
1
B
O
HOH
580
8.80
1
B
O
HOH
581
8.15
1
C
O
HOH
585
8.79
3PE
1,2-Distearoyl-sn-glycerophosphoethanolamine
HOH
water
PEH
300
2
3PE
3PE
300
A
HOH
503
3
HOH
HOH
503
A
HOH
507
3
HOH
HOH
507
A
HOH
509
3
HOH
HOH
509
A
HOH
513
3
HOH
HOH
513
A
HOH
515
3
HOH
HOH
515
A
HOH
516
3
HOH
HOH
516
A
HOH
517
3
HOH
HOH
517
A
HOH
518
3
HOH
HOH
518
A
HOH
519
3
HOH
HOH
519
A
HOH
530
3
HOH
HOH
530
A
HOH
531
3
HOH
HOH
531
A
HOH
537
3
HOH
HOH
537
A
HOH
539
3
HOH
HOH
539
A
HOH
541
3
HOH
HOH
541
A
HOH
543
3
HOH
HOH
543
A
HOH
548
3
HOH
HOH
548
A
HOH
551
3
HOH
HOH
551
A
HOH
555
3
HOH
HOH
555
A
HOH
559
3
HOH
HOH
559
A
HOH
562
3
HOH
HOH
562
A
HOH
564
3
HOH
HOH
564
A
HOH
565
3
HOH
HOH
565
A
HOH
566
3
HOH
HOH
566
A
HOH
567
3
HOH
HOH
567
A
HOH
568
3
HOH
HOH
568
A
HOH
569
3
HOH
HOH
569
A
HOH
584
3
HOH
HOH
584
A
HOH
588
3
HOH
HOH
588
A
HOH
589
3
HOH
HOH
589
A
HOH
501
3
HOH
HOH
501
B
HOH
502
3
HOH
HOH
502
B
HOH
504
3
HOH
HOH
504
B
HOH
508
3
HOH
HOH
508
B
HOH
512
3
HOH
HOH
512
B
HOH
520
3
HOH
HOH
520
B
HOH
522
3
HOH
HOH
522
B
HOH
526
3
HOH
HOH
526
B
HOH
532
3
HOH
HOH
532
B
HOH
533
3
HOH
HOH
533
B
HOH
540
3
HOH
HOH
540
B
HOH
544
3
HOH
HOH
544
B
HOH
546
3
HOH
HOH
546
B
HOH
547
3
HOH
HOH
547
B
HOH
549
3
HOH
HOH
549
B
HOH
550
3
HOH
HOH
550
B
HOH
560
3
HOH
HOH
560
B
HOH
561
3
HOH
HOH
561
B
HOH
563
3
HOH
HOH
563
B
HOH
570
3
HOH
HOH
570
B
HOH
571
3
HOH
HOH
571
B
HOH
572
3
HOH
HOH
572
B
HOH
580
3
HOH
HOH
580
B
HOH
581
3
HOH
HOH
581
B
HOH
590
3
HOH
HOH
590
B
HOH
505
3
HOH
HOH
505
C
HOH
506
3
HOH
HOH
506
C
HOH
510
3
HOH
HOH
510
C
HOH
511
3
HOH
HOH
511
C
HOH
514
3
HOH
HOH
514
C
HOH
521
3
HOH
HOH
521
C
HOH
523
3
HOH
HOH
523
C
HOH
524
3
HOH
HOH
524
C
HOH
525
3
HOH
HOH
525
C
HOH
527
3
HOH
HOH
527
C
HOH
528
3
HOH
HOH
528
C
HOH
529
3
HOH
HOH
529
C
HOH
534
3
HOH
HOH
534
C
HOH
535
3
HOH
HOH
535
C
HOH
536
3
HOH
HOH
536
C
HOH
538
3
HOH
HOH
538
C
HOH
542
3
HOH
HOH
542
C
HOH
545
3
HOH
HOH
545
C
HOH
552
3
HOH
HOH
552
C
HOH
553
3
HOH
HOH
553
C
HOH
554
3
HOH
HOH
554
C
HOH
556
3
HOH
HOH
556
C
HOH
557
3
HOH
HOH
557
C
HOH
558
3
HOH
HOH
558
C
HOH
573
3
HOH
HOH
573
C
HOH
574
3
HOH
HOH
574
C
HOH
575
3
HOH
HOH
575
C
HOH
576
3
HOH
HOH
576
C
HOH
577
3
HOH
HOH
577
C
HOH
578
3
HOH
HOH
578
C
HOH
579
3
HOH
HOH
579
C
HOH
582
3
HOH
HOH
582
C
HOH
583
3
HOH
HOH
583
C
HOH
585
3
HOH
HOH
585
C
HOH
586
3
HOH
HOH
586
C
HOH
587
3
HOH
HOH
587
C
n
1
-1
A
n
2
0
A
GLY
1
n
3
GLY
1
A
ASP
2
n
4
ASP
2
A
VAL
3
n
5
VAL
3
A
CYS
4
n
6
CYS
4
A
GLN
5
n
7
GLN
5
A
ASP
6
n
8
ASP
6
A
CYS
7
n
9
CYS
7
A
ILE
8
n
10
ILE
8
A
GLN
9
n
11
GLN
9
A
MET
10
n
12
MET
10
A
VAL
11
n
13
VAL
11
A
THR
12
n
14
THR
12
A
ASP
13
n
15
ASP
13
A
ILE
14
n
16
ILE
14
A
GLN
15
n
17
GLN
15
A
THR
16
n
18
THR
16
A
ALA
17
n
19
ALA
17
A
VAL
18
n
20
VAL
18
A
ARG
19
n
21
ARG
19
A
THR
20
n
22
THR
20
A
ASN
21
n
23
ASN
21
A
SER
22
n
24
SER
22
A
THR
23
n
25
THR
23
A
PHE
24
n
26
PHE
24
A
VAL
25
n
27
VAL
25
A
GLN
26
n
28
GLN
26
A
ALA
27
n
29
ALA
27
A
LEU
28
n
30
LEU
28
A
VAL
29
n
31
VAL
29
A
GLU
30
n
32
GLU
30
A
HIS
31
n
33
HIS
31
A
VAL
32
n
34
VAL
32
A
LYS
33
n
35
LYS
33
A
GLU
34
n
36
GLU
34
A
GLU
35
n
37
GLU
35
A
CYS
36
n
38
CYS
36
A
ASP
37
n
39
ASP
37
A
ARG
38
n
40
ARG
38
A
LEU
39
n
41
LEU
39
A
GLY
40
n
42
GLY
40
A
PRO
41
n
43
PRO
41
A
GLY
42
n
44
GLY
42
A
MET
43
n
45
MET
43
A
ALA
44
n
46
ALA
44
A
ASP
45
n
47
ASP
45
A
ILE
46
n
48
ILE
46
A
CYS
47
n
49
CYS
47
A
LYS
48
n
50
LYS
48
A
ASN
49
n
51
ASN
49
A
TYR
50
n
52
TYR
50
A
ILE
51
n
53
ILE
51
A
SER
52
n
54
SER
52
A
GLN
53
n
55
GLN
53
A
TYR
54
n
56
TYR
54
A
SER
55
n
57
SER
55
A
GLU
56
n
58
GLU
56
A
ILE
57
n
59
ILE
57
A
ALA
58
n
60
ALA
58
A
ILE
59
n
61
ILE
59
A
GLN
60
n
62
GLN
60
A
MET
61
n
63
MET
61
A
MET
62
n
64
MET
62
A
MET
63
n
65
MET
63
A
HIS
64
n
66
HIS
64
A
MET
65
n
67
MET
65
A
GLN
66
n
68
GLN
66
A
PRO
67
n
69
PRO
67
A
LYS
68
n
70
LYS
68
A
GLU
69
n
71
GLU
69
A
ILE
70
n
72
ILE
70
A
CYS
71
n
73
CYS
71
A
ALA
72
n
74
ALA
72
A
LEU
73
n
75
LEU
73
A
VAL
74
n
76
VAL
74
A
GLY
75
n
77
GLY
75
A
PHE
76
n
78
PHE
76
A
CYS
77
n
79
CYS
77
A
ASP
78
n
80
ASP
78
A
n
81
79
A
MET
-1
n
1
MET
-1
B
ASP
0
n
2
ASP
0
B
GLY
1
n
3
GLY
1
B
ASP
2
n
4
ASP
2
B
VAL
3
n
5
VAL
3
B
CYS
4
n
6
CYS
4
B
GLN
5
n
7
GLN
5
B
ASP
6
n
8
ASP
6
B
CYS
7
n
9
CYS
7
B
ILE
8
n
10
ILE
8
B
GLN
9
n
11
GLN
9
B
MET
10
n
12
MET
10
B
VAL
11
n
13
VAL
11
B
THR
12
n
14
THR
12
B
ASP
13
n
15
ASP
13
B
ILE
14
n
16
ILE
14
B
GLN
15
n
17
GLN
15
B
THR
16
n
18
THR
16
B
ALA
17
n
19
ALA
17
B
VAL
18
n
20
VAL
18
B
ARG
19
n
21
ARG
19
B
THR
20
n
22
THR
20
B
ASN
21
n
23
ASN
21
B
SER
22
n
24
SER
22
B
THR
23
n
25
THR
23
B
PHE
24
n
26
PHE
24
B
VAL
25
n
27
VAL
25
B
GLN
26
n
28
GLN
26
B
ALA
27
n
29
ALA
27
B
LEU
28
n
30
LEU
28
B
VAL
29
n
31
VAL
29
B
GLU
30
n
32
GLU
30
B
HIS
31
n
33
HIS
31
B
VAL
32
n
34
VAL
32
B
LYS
33
n
35
LYS
33
B
GLU
34
n
36
GLU
34
B
GLU
35
n
37
GLU
35
B
CYS
36
n
38
CYS
36
B
ASP
37
n
39
ASP
37
B
ARG
38
n
40
ARG
38
B
LEU
39
n
41
LEU
39
B
GLY
40
n
42
GLY
40
B
PRO
41
n
43
PRO
41
B
GLY
42
n
44
GLY
42
B
MET
43
n
45
MET
43
B
ALA
44
n
46
ALA
44
B
ASP
45
n
47
ASP
45
B
ILE
46
n
48
ILE
46
B
CYS
47
n
49
CYS
47
B
LYS
48
n
50
LYS
48
B
ASN
49
n
51
ASN
49
B
TYR
50
n
52
TYR
50
B
ILE
51
n
53
ILE
51
B
SER
52
n
54
SER
52
B
GLN
53
n
55
GLN
53
B
TYR
54
n
56
TYR
54
B
SER
55
n
57
SER
55
B
GLU
56
n
58
GLU
56
B
ILE
57
n
59
ILE
57
B
ALA
58
n
60
ALA
58
B
ILE
59
n
61
ILE
59
B
GLN
60
n
62
GLN
60
B
MET
61
n
63
MET
61
B
MET
62
n
64
MET
62
B
MET
63
n
65
MET
63
B
HIS
64
n
66
HIS
64
B
MET
65
n
67
MET
65
B
GLN
66
n
68
GLN
66
B
PRO
67
n
69
PRO
67
B
LYS
68
n
70
LYS
68
B
GLU
69
n
71
GLU
69
B
ILE
70
n
72
ILE
70
B
CYS
71
n
73
CYS
71
B
ALA
72
n
74
ALA
72
B
LEU
73
n
75
LEU
73
B
VAL
74
n
76
VAL
74
B
GLY
75
n
77
GLY
75
B
PHE
76
n
78
PHE
76
B
CYS
77
n
79
CYS
77
B
ASP
78
n
80
ASP
78
B
n
81
79
B
n
1
-1
C
n
2
0
C
GLY
1
n
3
GLY
1
C
ASP
2
n
4
ASP
2
C
VAL
3
n
5
VAL
3
C
CYS
4
n
6
CYS
4
C
GLN
5
n
7
GLN
5
C
ASP
6
n
8
ASP
6
C
CYS
7
n
9
CYS
7
C
ILE
8
n
10
ILE
8
C
GLN
9
n
11
GLN
9
C
MET
10
n
12
MET
10
C
VAL
11
n
13
VAL
11
C
THR
12
n
14
THR
12
C
ASP
13
n
15
ASP
13
C
ILE
14
n
16
ILE
14
C
GLN
15
n
17
GLN
15
C
THR
16
n
18
THR
16
C
ALA
17
n
19
ALA
17
C
VAL
18
n
20
VAL
18
C
ARG
19
n
21
ARG
19
C
THR
20
n
22
THR
20
C
ASN
21
n
23
ASN
21
C
SER
22
n
24
SER
22
C
THR
23
n
25
THR
23
C
PHE
24
n
26
PHE
24
C
VAL
25
n
27
VAL
25
C
GLN
26
n
28
GLN
26
C
ALA
27
n
29
ALA
27
C
LEU
28
n
30
LEU
28
C
VAL
29
n
31
VAL
29
C
GLU
30
n
32
GLU
30
C
HIS
31
n
33
HIS
31
C
VAL
32
n
34
VAL
32
C
LYS
33
n
35
LYS
33
C
GLU
34
n
36
GLU
34
C
GLU
35
n
37
GLU
35
C
CYS
36
n
38
CYS
36
C
ASP
37
n
39
ASP
37
C
ARG
38
n
40
ARG
38
C
LEU
39
n
41
LEU
39
C
GLY
40
n
42
GLY
40
C
PRO
41
n
43
PRO
41
C
GLY
42
n
44
GLY
42
C
MET
43
n
45
MET
43
C
ALA
44
n
46
ALA
44
C
ASP
45
n
47
ASP
45
C
ILE
46
n
48
ILE
46
C
CYS
47
n
49
CYS
47
C
LYS
48
n
50
LYS
48
C
ASN
49
n
51
ASN
49
C
TYR
50
n
52
TYR
50
C
ILE
51
n
53
ILE
51
C
SER
52
n
54
SER
52
C
GLN
53
n
55
GLN
53
C
TYR
54
n
56
TYR
54
C
SER
55
n
57
SER
55
C
GLU
56
n
58
GLU
56
C
ILE
57
n
59
ILE
57
C
ALA
58
n
60
ALA
58
C
ILE
59
n
61
ILE
59
C
GLN
60
n
62
GLN
60
C
MET
61
n
63
MET
61
C
MET
62
n
64
MET
62
C
MET
63
n
65
MET
63
C
HIS
64
n
66
HIS
64
C
MET
65
n
67
MET
65
C
GLN
66
n
68
GLN
66
C
PRO
67
n
69
PRO
67
C
LYS
68
n
70
LYS
68
C
GLU
69
n
71
GLU
69
C
ILE
70
n
72
ILE
70
C
CYS
71
n
73
CYS
71
C
ALA
72
n
74
ALA
72
C
LEU
73
n
75
LEU
73
C
VAL
74
n
76
VAL
74
C
GLY
75
n
77
GLY
75
C
PHE
76
n
78
PHE
76
C
CYS
77
n
79
CYS
77
C
ASP
78
n
80
ASP
78
C
n
81
79
C
author_and_software_defined_assembly
PISA
2
dimeric
author_defined_assembly
2
dimeric
4160
-50
8840
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
-0.5000000000
-0.8660254038
0.0000000000
-0.8660254038
0.5000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
6_555
-x,-x+y,-z+1/3
crystal symmetry operation
0.0000000000
0.0000000000
31.4553333333
1
A
C3F
3PE
300
D
C3F
3PE
1
1
N
1
A
C3G
3PE
300
D
C3G
3PE
1
1
N
1
A
C3H
3PE
300
D
C3H
3PE
1
1
N
1
A
C3I
3PE
300
D
C3I
3PE
1
1
N
1
A
C2I
3PE
300
D
C2I
3PE
1
1
N
1
A
MET
-1
A
MET
1
1
Y
1
A
ASP
0
A
ASP
2
1
Y
1
A
GLU
79
A
GLU
81
1
Y
1
B
GLU
79
B
GLU
81
1
Y
1
C
MET
-1
C
MET
1
1
Y
1
C
ASP
0
C
ASP
2
1
Y
1
C
GLU
79
C
GLU
81
1
Y
1
A
B
OD2
OD2
ASP
ASP
6
13
2.12
1
7.21
1.10
114.20
121.41
B
B
B
CA
CB
SG
CYS
CYS
CYS
47
47
47
N
1
A
SER
22
-58.68
-9.80
1
B
SER
22
-58.51
-6.81
1
C
ASP
37
-39.07
-37.21
1
C
ARG
38
-60.16
1.64
PROTEIN_REP.PARAM
PROTEIN.TOP
WATER_REP.PARAM
WATER.TOP
PEH.PARAM
PEH.TOP
45.8
-3.05
1.75
0.00
-3.05
0.00
6.11
0.262
0.010
0.222
0.222
2.20
19.74
729
14613
5.0
98.3
RANDOM
1
RESTRAINED
THROUGHOUT
0.0
MAD
Engh & Huber
FLAT MODEL
52.3682
0.321762
0.31
0.22
2.20
19.74
90
1955
46
0
1819
0.008
1.2
18.3
0.82
0.291
0.028
0.235
2.34
110
2096
6
5.0
90.8
22.7
2.2
37.0
1N69
14644
14644
0.059
1
9
10.5
98.3
2.20
2.32
2.6
14644
0.289
5.3
98.3
data reduction
MOSFLM
data scaling
SCALA
phasing
SnB
phasing
SHARP
model building
DM
refinement
CNS
1.1
data scaling
CCP4
(SCALA)
Proactivator polypeptide, DI-STEAROYL-3-SN-PHOSPHATIDYLETHANOLAMINE
Crystal structure of human saposin B
1
N
N
1
N
N
1
N
N
2
N
N
3
N
N
3
N
N
3
N
N
A
GLY
1
A
GLY
3
HELX_P
A
ASN
21
A
ASN
23
1
1
21
A
THR
23
A
THR
25
HELX_P
A
CYS
36
A
CYS
38
1
2
14
A
ASP
37
A
ASP
39
HELX_P
A
GLY
40
A
GLY
42
5
3
4
A
GLY
42
A
GLY
44
HELX_P
A
MET
63
A
MET
65
1
4
22
A
GLN
66
A
GLN
68
HELX_P
A
VAL
74
A
VAL
76
1
5
9
B
ASP
2
B
ASP
4
HELX_P
B
ASN
21
B
ASN
23
1
6
20
B
VAL
25
B
VAL
27
HELX_P
B
GLU
35
B
GLU
37
1
7
11
B
CYS
36
B
CYS
38
HELX_P
B
GLY
40
B
GLY
42
5
8
5
B
GLY
42
B
GLY
44
HELX_P
B
MET
63
B
MET
65
1
9
22
B
GLN
66
B
GLN
68
HELX_P
B
VAL
74
B
VAL
76
1
10
9
C
GLY
1
C
GLY
3
HELX_P
C
ASN
21
C
ASN
23
1
11
21
C
THR
23
C
THR
25
HELX_P
C
ASP
37
C
ASP
39
1
12
15
C
ARG
38
C
ARG
40
HELX_P
C
GLY
40
C
GLY
42
5
13
3
C
GLY
42
C
GLY
44
HELX_P
C
MET
63
C
MET
65
1
14
22
C
GLN
66
C
GLN
68
HELX_P
C
GLY
75
C
GLY
77
1
15
10
disulf
2.040
A
CYS
4
A
SG
CYS
6
1_555
A
CYS
77
A
SG
CYS
79
1_555
disulf
2.042
A
CYS
7
A
SG
CYS
9
1_555
A
CYS
71
A
SG
CYS
73
1_555
disulf
2.034
A
CYS
36
A
SG
CYS
38
1_555
A
CYS
47
A
SG
CYS
49
1_555
disulf
2.049
B
CYS
4
B
SG
CYS
6
1_555
B
CYS
77
B
SG
CYS
79
1_555
disulf
2.046
B
CYS
7
B
SG
CYS
9
1_555
B
CYS
71
B
SG
CYS
73
1_555
disulf
2.031
B
CYS
36
B
SG
CYS
38
1_555
B
CYS
47
B
SG
CYS
49
1_555
disulf
2.043
C
CYS
4
C
SG
CYS
6
1_555
C
CYS
77
C
SG
CYS
79
1_555
disulf
2.046
C
CYS
7
C
SG
CYS
9
1_555
C
CYS
71
C
SG
CYS
73
1_555
disulf
2.035
C
CYS
36
C
SG
CYS
38
1_555
C
CYS
47
C
SG
CYS
49
1_555
LIPID BINDING PROTEIN
LIPID BINDING PROTEIN, GLYCOSPHINGOLIPID ACTIVATOR PROTEIN
SAP_HUMAN
UNP
1
195
P07602
GDVCQDCIQMVTDIQTAVRTNSTFVQALVEHVKEECDRLGPGMADICKNYISQYSEIAIQMMMHMQPKEICALVGFCDE
195
273
1N69
1
79
P07602
A
1
3
81
195
273
1N69
1
79
P07602
B
1
3
81
195
273
1N69
1
79
P07602
C
1
3
81
1
cloning artifact
MET
-1
1N69
A
P07602
UNP
1
1
cloning artifact
ASP
0
1N69
A
P07602
UNP
2
2
cloning artifact
MET
-1
1N69
B
P07602
UNP
1
2
cloning artifact
ASP
0
1N69
B
P07602
UNP
2
3
cloning artifact
MET
-1
1N69
C
P07602
UNP
1
3
cloning artifact
ASP
0
1N69
C
P07602
UNP
2
BINDING SITE FOR RESIDUE 3PE A 300
A
3PE
300
Software
11
A
ARG
38
A
ARG
40
11
1_555
A
LEU
39
A
LEU
41
11
1_555
A
MET
43
A
MET
45
11
1_555
A
ILE
51
A
ILE
53
11
1_555
A
GLN
66
A
GLN
68
11
6_655
A
HOH
515
E
HOH
11
6_655
B
VAL
29
B
VAL
31
11
1_555
B
TYR
50
B
TYR
52
11
1_555
B
TYR
54
B
TYR
56
11
1_555
B
ILE
59
B
ILE
61
11
1_555
B
MET
65
B
MET
67
11
1_555
152
P 31 2 1